封面
市場調查報告書
商品編碼
1866516

生命科學設備市場-2025-2030年預測

Life Science Instrumentation Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計生命科學設備市場將從 2025 年的 665.41 億美元快速成長到 2030 年的 896.79 億美元,複合年成長率為 6.15%。

生命科學儀器市場正經歷強勁成長,這主要得益於其在生物技術、製藥、食品飲料和環境監測等領域推動研究、診斷和工業應用的關鍵作用。這些儀器能夠促進前沿創新,改善治療效果,並支持生產過程中的品管。主要成長要素包括製藥業在藥物研發方面投入的不斷增加、感染疾病流行以及食品飲料行業消費者健康意識的增強。此外,蛋白質體學市場的擴張和日益成長的環境問題也推動了對先進儀器的需求。

市場促進因素

製藥業專注於藥物發現和開發是其主要成長要素,而生命科學設備在這些過程中至關重要。感染疾病率的上升進一步推動了對診斷工具的需求,尤其是在臨床環境中。在食品飲料產業,意識提升推動了品質保證和檢測設備的普及。高度依賴精確分析工具的蛋白質體學市場也促進了市場擴張。此外,日益成長的環境問題也推動了監測和檢測設備的使用,以確保符合監管標準。主要市場參與者持續的研發投入預計將在未來幾年進一步推動市場成長。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章:生命科學設備市場(依技術分類)

  • 介紹
  • 光譜學
  • 層析法
  • 流式細胞技術
  • 其他

第6章:生命科學設備市場(依應用領域分類)

  • 介紹
  • 分析化學
  • 臨床分析
  • 環境測試
  • 食品/飲料分析
  • 其他

第7章 生命科學設備市場(依最終用戶分類)

  • 介紹
  • 醫院
  • 研究所
  • 診斷檢查室
  • 其他

第8章:生命科學設備市場區域分類

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章:競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章:公司簡介

  • Shimadzu Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Danaher Corporation
  • Hitachi High-Technologies Corporation
  • Thermo Fisher Scientific Inc.
  • Bruker Corporation
  • General Electric Company

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061611899

The Life Science Instrumentation Market is projected to surge from USD 66.541 billion in 2025 to USD 89.679 billion by 2030, at a CAGR of 6.15%.

The life science instrumentation market is experiencing robust growth, driven by its critical role in advancing research, diagnostics, and industrial applications across biotechnology, pharmaceuticals, food and beverage, and environmental monitoring. These instruments enable cutting-edge innovations, improve treatment outcomes, and support quality control in manufacturing processes. Key drivers include increased pharmaceutical investments in drug discovery, rising infectious disease prevalence, and growing consumer health awareness in the food and beverage sector. Additionally, the expanding proteomics market and heightened environmental concerns are bolstering demand for advanced instrumentation.

Market Drivers

The pharmaceutical industry's focus on drug discovery and development is a primary growth driver, as life science instruments are integral to these processes. The rising incidence of infectious diseases has further amplified demand for diagnostic tools, particularly in clinical settings. In the food and beverage industry, growing consumer awareness of health and safety standards has spurred the adoption of instrumentation for quality assurance and testing. The proteomics market, which relies heavily on precise analytical tools, is also contributing to market expansion. Moreover, increasing environmental concerns have driven the use of instrumentation for monitoring and testing, ensuring compliance with regulatory standards. Sustained research and development efforts by key market players are expected to further propel market growth in the coming years.

Market Segmentation

The life science instrumentation market is segmented by technology, application, end-user, and geography. By technology, the market includes spectroscopy, chromatography, flow cytometry, and other advanced methods, each catering to specific analytical needs. By application, the market covers analytical chemistry, clinical analysis, environmental testing, food and beverage analysis, and other specialized areas, reflecting the diverse utility of these instruments. End-users include hospitals, research institutes, diagnostic laboratories, and other facilities, with each sector leveraging instrumentation for diagnostics, research, or quality control. This segmentation highlights the market's versatility across scientific and industrial domains.

Geographic Insights

While specific geographic trends are not detailed, the global nature of the market suggests strong growth in regions with robust pharmaceutical, biotechnology, and food industries. Developing economies with increasing healthcare and environmental investments are likely to contribute significantly to market expansion, alongside established markets with advanced research infrastructures.

Key Developments (2023-2025)

Notable advancements include Bruker Corporation's launch of the INVENIO X Fourier Transform Infrared system, designed for advanced molecular spectroscopy research. Additionally, Bio-Rad Laboratories Inc. introduced the BioPlex 2200 Lyme Total Assay, a US FDA-cleared platform aiding in the diagnosis of Lyme disease, enhancing diagnostic precision in clinical settings.

Key Players

Leading companies such as Bruker Corporation and Bio-Rad Laboratories Inc. are driving innovation through advanced product offerings and strategic R&D investments. These players are strengthening their market positions by addressing the growing demand for precise, reliable instrumentation across diverse applications.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Technology

  • Spectroscopy
  • Chromatography
  • Flow Cytometry
  • Others

By Application

  • Analytical Chemistry
  • Clinical Analysis
  • Environmental Testing
  • Food and Beverage Analysis
  • Others

By End-Users

  • Hospitals
  • Research Institutes
  • Diagnostic Laboratories
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LIFE SCIENCE INSTRUMENTATION MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Spectroscopy
  • 5.3. Chromatography
  • 5.4. Flow Cytometry
  • 5.5. Others

6. LIFE SCIENCE INSTRUMENTATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Analytical Chemistry
  • 6.3. Clinical Analysis
  • 6.4. Environmental Testing
  • 6.5. Food and Beverage Analysis
  • 6.6. Others

7. LIFE SCIENCE INSTRUMENTATION MARKET BY END-USERS

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Research Institutes
  • 7.4. Diagnostic Laboratories
  • 7.5. Others

8. LIFE SCIENCE INSTRUMENTATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Shimadzu Corporation
  • 10.2. Bio-Rad Laboratories, Inc.
  • 10.3. Becton, Dickinson and Company
  • 10.4. PerkinElmer, Inc.
  • 10.5. Danaher Corporation
  • 10.6. Hitachi High-Technologies Corporation
  • 10.7. Thermo Fisher Scientific Inc.
  • 10.8. Bruker Corporation
  • 10.9. General Electric Company

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations